Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony, -- Ignore unavailable to you. Want to Upgrade?

To: LTK007 who wrote (26654)	4/5/1999 9:13:00 AM
From: Richard Miller	Read Replies (2) \| Respond to of 122087

What I said was I did not find it "compelling". Yes the hospital "determined" the 5 % of initial users having heart attacks was a coincidence, hmmm. Also 4 or 5 initial participants opted to leave the study, hmmm. I heard of no brain cancers it cured. hmmm. Many patients who had the cancers only experienced arresting not shrinkage or remission. It's all very nice. I wish them the best, but 60 minutes calibre --no. Also the last sentence in the story was that there were 19 other similar drugs in hospital trial. What about those? Compare that with IMCL's results.